What is Syncom Formulation (India) Operating Cash Flow per Share?
Syncom Formulation (India)'s operating cash flow per share for the
three
months ended in Mar. 2024 was ₹0.00.
Syncom Formulation (India)'s operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Syncom Formulation (India) was -163.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -45.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Syncom Formulation (India)'s Operating Cash Flow per Share or its related term are showing as below:
NSE:SYNCOMF'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -71 Med: -5.7 Max: 60.9
Current: -45.4
During the past 13 years, Syncom Formulation (India)'s highest 3-Year average Operating Cash Flow per Share Growth Rate was 60.90% per year. The lowest was -71.00% per year. And the median was -5.70% per year.
NSE:SYNCOMF's 3-Year OCF Growth Rate is ranked better than 63.03% of 806
companies
in the Drug Manufacturers industry
Industry Median: 6.9
vs NSE:SYNCOMF: -45.40
Syncom Formulation (India) Operating Cash Flow per Share Historical Data
The historical data trend for Syncom Formulation (India)'s Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Syncom Formulation (India) Operating Cash Flow per Share Chart
Competitive Comparison of Syncom Formulation (India)'s Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syncom Formulation (India)'s Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Syncom Formulation (India)'s Price-to-Operating-Cash-Flow falls into.
Syncom Formulation (India) Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Syncom Formulation (India)'s Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syncom Formulation (India) Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Syncom Formulation (India)'s Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Syncom Formulation (India) (NSE:SYNCOMF) Business Description
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:SYNCOMF has been successfully added to your 